We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

By MedImaging International staff writers
Posted on 16 Sep 2025
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost always returns because hidden cancer cells remain in surrounding tissues. Current imaging and dye-based methods fail to detect cells that have migrated beyond the visible tumor margin. Now, a new method based on fluid moving through and near the tumor can better identify where these invasive cells are likely to reappear.

This novel approach, created by researchers at the Fralin Biomedical Research Institute at VTC, combines magnetic resonance imaging (MRI), fluid dynamics knowledge, and a custom algorithm. The method builds on the study of interstitial fluid flow, which describes how fluid moves between cells in tissues. By modeling these flows, the algorithm predicts pathways that tumor cells use to migrate, identifying high-risk areas for recurrence beyond what standard scans reveal.

According to the researchers, faster interstitial flows around a tumor correlated with higher rates of invasion, while more random fluid diffusion corresponded to less spread. The most powerful predictor was a new metric showing how flows converge into pathlines, like streams merging into rivers, which cancer cells follow. These insights, published in npj Biomedical Innovations, demonstrate that fluid flow patterns can highlight hotspots of hidden tumor cells that standard imaging cannot detect.

This predictive model could provide surgeons and oncologists with probability maps to guide more precise and aggressive interventions where tumor cells are most likely to be. It could also spare healthy brain regions from unnecessary treatment by identifying areas with lower invasion risk. These findings are being translated into clinical tools that support personalized surgical and radiation strategies for glioblastoma patients.

“If you can't find the tumor cells, you can't kill the tumor cells, whether that's by cutting them out, hitting them with radiation therapy, or getting drugs to them. This is a method that we now believe can allow us to find those tumor cells,” said Jennifer Munson, PhD, Professor and Director of the Cancer Research Center — Roanoke at the Fralin Biomedical Research Institute at VTC. “This could tell a surgeon where there's going to be a higher chance of there being more tumor cells, so they might be a little more aggressive, if it's safe to the patient to go after a more invasive region.”

Adjustable Mobile Barrier
M-458
Half Apron
Demi
Mobile X-Ray System
K4W
Digital Radiographic System
OMNERA 300M

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.